Conditions: COPD
Keywords: COPD
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 629
Healthy volunteers: no

Brief summary:
To compare the efficacy, safety and pharmacokinetics of QMF149 delivered via Concept1 to salmeterol xinafoate/fluticasone propionate delivered via Accuhaler in adult patients with COPD

Detailed description:

Arms:
arm 1: QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 µg o.d. delivered via Concept1 device arm 2: Salmeterol xinafoate/fluticasone propionate 50/500 µg b.i.d, delivered via Accuhaler®

Interventions: intervention 1: QMF149 intervention 2: Salmeterol
Intervention descriptions: intervention 1: delivered via Concept1 device intervention 2: delivered via Accuhaler®

Protocol document: